Voya Investment Management LLC Intellia Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$85.7 Billion
Q2 2024

A detailed history of Voya Investment Management LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 31,908 shares of NTLA stock, worth $670,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,908

Previous 81,041 60.63%

Holding current value

$670,387

Previous $2.23 Million 67.97%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $983,642 - $1.34 Million	-49,133 Reduced 60.63%	31,908 $714,000
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $325,833 - $448,671	-13,679 Reduced 14.44%	81,041 $2.23 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $884,017 - $1.23 Million	38,170 Added 67.5%	94,720 $2.89 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $686,248 - $993,563	21,703 Added 62.28%	56,550 $1.79 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $1.37 Million - $1.82 Million	-39,551 Reduced 53.16%	34,847 $1.42 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $1.25 Million - $1.69 Million	-37,678 Reduced 33.62%	74,398 $2.77 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $100,061 - $188,884	3,013 Added 2.76%	112,076 $3.91 Million
Q3 2022 Mar 03, 2023	SELL	$53.92 - $71.7 $162,460 - $216,032	-3,013 Reduced 2.69%	109,063 $6.1 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $2.09 Million - $2.78 Million	38,748 Added 55.11%	109,063 $6.1 Million
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $4.39 Million - $8.69 Million	-114,058 Reduced 61.86%	70,315 $3.64 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $9.17 Million - $18.7 Million	157,452 Added 584.87%	184,373 $13.4 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $16,121 - $22,137	160 Added 0.6%	26,921 $3.18 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $219,998 - $293,808	1,662 Added 6.62%	26,761 $3.59 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $63,924 - $170,005	1,050 Added 4.37%	25,099 $4.06 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $93,086 - $167,192	1,998 Added 9.06%	24,049 $1.93 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $103,226 - $348,271	5,482 Added 33.09%	22,051 $1.2 Million
Q3 2020 Nov 16, 2020	BUY	$17.47 - $24.93 $22,693 - $32,384	1,299 Added 8.51%	16,569 $329,000
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $46,743 - $95,962	-4,196 Reduced 21.56%	15,270 $321,000
Q1 2020 May 15, 2020	BUY	$9.44 - $15.58 $8,486 - $14,006	899 Added 4.84%	19,466 $238,000
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $40,405 - $68,453	3,874 Added 26.37%	18,567 $272,000
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $5,080 - $6,738	366 Added 2.55%	14,693 $241,000
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $17,290 - $41,183	1,518 Added 11.85%	14,327 $196,000
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $256,436 - $394,389	12,809 New	12,809 $350,000

Others Institutions Holding NTLA

# of Institutions

326

Shares Held

88.8M

Call Options Held

673K

Put Options Held

865K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.6B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Intellia Therapeutics, Inc. Transaction History